Concepedia

Efficacy and safety of the selective co-stimulation modulator abatacept following 2 years of treatment in patients with rheumatoid arthritis and an inadequate response to anti-tumour necrosis factor therapy

Mark C. Genovese, M. Schiff, Michael E. Luggen, J-C Becker, R. Aranda, J. Teng, T. Li, N. Schmidely, Manuela Le Bars, Maxime Dougados

Annals of the Rheumatic Diseases · 2007 · 266 citations · 18 references

DOI

References

18

The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection.

John E. Ware, Cathy D. Sherbourne · PubMed · 1992 · 34K citations

, , +22

The MOS 36-ltem Short-Form Health Survey (SF-36)

John E. Ware, Cathy D. Sherbourne · Medical Care · 1992 · 29.1K citations

, , +14

Infliximab and Methotrexate in the Treatment of Rheumatoid Arthritis

Peter E. Lipsky, Désirée van der Heijde, E. William St. Clair et al. · New England Journal of Medicine · 2000 · 3K citations · Full text

American college of rheumatology preliminary definition of improvement in rheumatoid arthritis

David T. Felson, Jennifer J. Anderson, Maarten Boers et al. · Arthritis & Rheumatism · 1995 · 2.8K citations

Infliximab (chimeric anti-tumour necrosis factor α monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomised phase III trial

Ravinder N. Maini, E. William St. Clair, Ferdinand C. Breedveld et al. · The Lancet · 1999 · 2.3K citations

, , +14